Serial Number | 79391313 |
Word Mark | BCAL DX |
Filing Date | Tuesday, January 23, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, December 31, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 31, 2024 |
Goods and Services | Chemical preparations for testing blood for medical purposes; diagnostic preparations for clinical, medical or veterinary laboratory use; diagnostic preparations for medical purposes; diagnostic products in the nature of medical diagnostic biomarkers for medical purposes; diagnostic substances for medical use; diagnostic testing materials in the nature of diagnostic test patch for application to the skin for determining allergies for medical use; diagnostic agents for pharmaceutical use; diagnostic reagents for medical purposes; preparations for medical diagnostic use; reagents for blood grouping for medical purposes; blood testing apparatus including test erythrocytes for blood diagnostic purposes; medical adhesive tapes; medical dressings; medical or veterinary chemical products in the nature of chemical reagents for diagnostic tests for medical use; medical or veterinary chemical products in the nature of chemical reagents for use in biological preparations for medical purposes; medical or veterinary chemical products in the nature of chemical reagents for use with biotechnology for medical purposes; medical or veterinary chemical preparations in the nature of chemical reagents for the vaccines and antibodies chemical products in the nature of chemical reagents and antibody reagents for the detection of antigens in cells and tissue for medical and veterinary purposes; medical or veterinary chemical preparations for therapeutic , sanitary pharmaceutical purposes for modulating or modifying lipids to improve disease outcomes for conditions including, dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical plasters; medical preparations for the treatment of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical wound dressings |
Goods and Services | Medical analysis of tissues for the medical treatment of persons; blood testing services being medical analysis services for diagnostic and treatment purposes by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the diagnosis and treatment of persons; medical analysis services relating to the treatment of patients; medical diagnostic testing, monitoring and reporting services; surgical diagnostic services relating to the treatment of patients for medical purposes; health screening services in the field of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical screening; medical services; medical monitoring and reporting services of patients; remote monitoring of medical data for medical diagnosis and treatment |
Goods and Services | Diagnostic apparatus for carrying out diagnostic tests for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells used in medical laboratories for medical purposes; diagnostic apparatus for diagnostic and medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells; diagnostic apparatus for medical diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and apparatus for blood analysis; blood testing apparatus for blood tests; apparatus for testing blood; medical apparatus for use in blood analysis; medical apparatus for the treatment of cancer; blood cell analyzing apparatus for medical use; blood component separation apparatus for medical use; blood sampling apparatus for medical use; blood testing apparatus; blood testing equipment, namely, hematology analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and electromagnetic medical diagnostic imaging apparatus for medical use; immunochemical medical diagnostic testing apparatus for use in detecting and measuring antibody levels immunoassay procedures; immunochemical medical diagnostic testing instruments for use in detecting and measuring antibody levels immunoassay procedure; electromedical diagnostic instruments, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; gamma instruments for measuring human cell attenuation for medical use, namely, gamma cameras for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and medical apparatus for diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells and medical diagnostic apparatus for use in testing blood in medical laboratories; medical apparatus for medical diagnostic testing of biological samples; medical diagnostic apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and medical diagnostic instruments for the analysis of body fluids; medical diagnostic testing apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and testing apparatus for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; tools for medical diagnostics, namely, tube for collection of blood samples, hematology analyzers, metabolite analyzers, nucleic acid analyzers for medical diagnostics uses |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | BCal Diagnostics Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | AU |
Party Name | BCal Diagnostics Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | AU |
Event Date | Event Description |
Thursday, March 14, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Wednesday, March 20, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, April 24, 2024 | APPLICATION FILING RECEIPT MAILED |
Monday, July 22, 2024 | ASSIGNED TO EXAMINER |
Monday, July 29, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, July 30, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Saturday, August 10, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Saturday, August 10, 2024 | REFUSAL PROCESSED BY MPU |
Saturday, August 31, 2024 | REFUSAL PROCESSED BY IB |
Friday, September 20, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, September 20, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, September 20, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, September 20, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, September 20, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, September 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, September 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, September 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, October 19, 2024 | FINAL REFUSAL WRITTEN |
Saturday, October 19, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Saturday, October 19, 2024 | FINAL REFUSAL E-MAILED |
Wednesday, December 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, December 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 4, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Thursday, December 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, December 31, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, December 31, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Saturday, January 4, 2025 | LIMITATION OF GOODS RECEIVED FROM IB |